Resalis Therapeutics is a biotech company aiming at treating Non-alcoholic Steatohepatitis (NASH) and other metabolic disorders.

The mission is to treat complex metabolic diseases, including NASH (non-alcoholic steatohepatitis) and obesity, developing safe and effective miRNA targeted therapies